Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Other Gross PP&E Adjustments (2016 - 2025)

Arcadia Biosciences' Other Gross PP&E Adjustments history spans 12 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 59.31% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 59.31%, while the annual FY2025 figure was $1.3 million, 59.31% up from the prior year.
  • Other Gross PP&E Adjustments reached $1.3 million in Q4 2025 per RKDA's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.6 million in Q3 2021 to a low of -$3.4 million in Q4 2023.
  • Average Other Gross PP&E Adjustments over 5 years is $1.6 million, with a median of $1.9 million recorded in 2025.
  • Peak YoY movement for Other Gross PP&E Adjustments: plummeted 343.12% in 2022, then skyrocketed 230.29% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.2 million in 2021, then tumbled by 343.12% to -$2.9 million in 2022, then decreased by 18.5% to -$3.4 million in 2023, then surged by 124.4% to $838000.0 in 2024, then skyrocketed by 59.31% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Other Gross PP&E Adjustments are $1.3 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025).